col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


123 Results       Page 1

 [1] 
Elsevier: Transplantation and Cellular Therapy
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―08 Haematopoietic stem cell (HSC) graft cryopreservation effects on outcomes of patients with haematological malignancies: the multi-centre UK experience during COVID-19 pandemic Dr Ruta Barkauskiene, Dr Angharad Pryce, Rachel Pearce, Prof. John A. Snowden, Dr Ram Malladi, Dr Victoria Potter, et al. (+8)
2 [GO] 2025―Feb―26 Long Donor Leukocyte Telomeres Increase the Risk of Severe COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplant Kyra J.W. Mendez, Tsung-Po Lai, Stephen R. Spellman, Simon Verhulst, James Anderson, Wael Saber, et al. (+2)
3 [GO] 2025―Feb―26 A Phase 3 Study to Evaluate Efficacy and Safety of Pemivibart, an IgG1 Monoclonal Antibody for Prevention of COVID-19 (CANOPY): Subset Analysis of Participants with Chronic Lymphocytic Leukemia Pamela Hawn, Kristin Narayan, Anne-Marie Phelan, Yong Li, Deepali Gupta, David Wilfret, Anna Holmes
4 [GO] 2025―Feb―26 Waning Long Term Efficacy of COVID-19 Post-Transplant Vaccination for Prevention of COVID-19 Adverse Events in Transplant and Cellular Therapy (TCT) Patients Rahul Ramaswamy, Laith Fakhoury, Peter Zhao, Ningying Wu, Feng Gao, Ramzi Abboud, et al. (+14)
5 [GO] 2024―Dec―14 A Retrospective Analysis of Fresh versus Cryopreserved Allogenic Bone Marrow Transplant within a Pediatric Population: A Change in Practice Due to the COVID-19 Pandemic Rhea Hans, Charlotte Schwalbach, Roberta H. Adams, Holly Miller, Dana Salzberg, Mohamad Sinno, et al. (+8)
6 [GO] 2024―Sep―24 COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence Hinpetch Daungsupawong, Viroj Wiwanitkit
7 [GO] 2024―Aug―23 COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics Emily A. Rosen, Elizabeth M. Krantz, Denise J. McCulloch, Marie H. Wilson, Frank Tverdek, Zahra Kassamali Escobar, et al. (+8)
8 [GO] 2024―May―05 Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes Among Allogeneic Stem Cell Transplant Patients with Early COVID-19 Infection Benjamin J. Lee, Pongthep Vittayawacharin, Shawn P. Griffin, Jean Doh, Hannah H. Nam, Deepa Jeyakumar, et al. (+3)
9 [GO] 2024―Mar―12 When four is more - improved COVID-19 antibody responses with 4 doses of vaccine in CAR T-cell therapy recipients Victoria G Hall
10 [GO] 2024―Feb―07 Impaired Immune Reconstitution and Worse Survival Outcomes Among Allogeneic Stem Cell Transplant Patients with Early COVID-19 Infection Benjamin J. Lee, Pongthep Vittayawacharin, Shawn Patrick Griffin, Jean Doh, Hannah H Nam, Emily Blodget, et al. (+3)
11 [GO] 2024―Feb―07 Retrospective Analysis of Fresh Vs Cryopreserved Allogenic Bone Marrow Transplant within Pediatric Population: A Change in Practice Due to COVID-19 Pandemic Rhea Hans, Charlotte Schwalbach, Dana Salzberg, Roberta Adams, Holly K. Miller, Mohamad Sinno, et al. (+4)
12 [GO] 2024―Feb―07 Sars-Cov-2 As a Potential Trigger for Renal Graft-Versus-Host Disease Following Allogenic Bone Marrow Transplant: A Case Series Report. Christine M. Murphy, Paritosh Prasad, Omar Aljitawi
13 [GO] 2024―Feb―07 Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, et al. (+22)
14 [GO] 2024―Feb―07 Navigating the Intersection of Multiple Myeloma and Severe Sars-Cov-2: Therapeutic Insights from Exosomal Vesicles Yan Leyfman, Gayathri P Menon, Muskan Joshi, Chandler Park
15 [GO] 2024―Feb―07 Assessment of the Relation between Infused Cell Dose and Clinical Outcomes of Autologous and Allogeneic Stem Cell Transplant Recipients By Patient Ethnicity before and during the COVID19 Pandemic. Mohammed Isaac Abu Zaanona, Graham Unis, Ernest Philon, Carl Haupt, Emma Hillis, Laura Finn
16 [GO] 2023―Dec―23 Efficacy of multiple SARS-CoV-2 vaccine doses in patients with B-cell hematologic malignancies receiving CAR-T therapy - A contemporary, cohort analysis Muhammad Bilal Abid, Micah Rubin, Aniko Szabo, Walter Longo, Timothy S. Fenske, Cole McCoy, et al. (+6)
17 [GO] 2023―Oct―06 Outcomes and Management of SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and Chimeric Antigen Receptor T cell (CART) therapy Maria-Stefania Infante, David Nemirovsky, Sean Devlin, Susan DeWolf, Roni Tamari, Parastoo B. Dahi, et al. (+12)
18 [GO] 2023―Aug―13 Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplant Recipients Ankit Mittal, Javier T Solera, Victor H. Ferreira, Sagar Kothari, Muneyoshi Kimura, Ivan Pasic, et al. (+6)
19 [GO] 2023―Jul―01 Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection Among Adult Long-Term Hematopoietic Cell Transplantation Survivors Emily C. Liang, Lynn E. Onstad, Paul Carpenter, Steven A. Pergam, Mary E. Flowers, Stephanie J. Lee, Catherine Liu
20 [GO] 2023―Jun―02 SERIOUS STEM CELL DONATION EVENTS AND RECIPIENT ADVERSE REACTIONS RELATED TO SARS-CoV-2: REVIEW OF REPORTS TO THE WORLD MARROW DONOR ASSOCIATION Rachel Pawson, Chloe Anthias, Meghann Cody, Mirjam Fechter, Diane Fournier, Elizabeth O'Flaherty, et al. (+3)
21 [GO] 2023―Mar―09 SARS-CoV-2 vaccine immunogenicity among chimeric antigen receptor T-cell therapy recipients Muneerah M Aleissa, Jessica S Little, Sonya Davey, Anna Saucier, Guohai Zhou, Isabel H. Gonzalez-Bocco, et al. (+7)
22 [GO] 2023―Feb―06 Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program Heather E. Stefanski, Jennifer Novakovich, Jennifer Newman, Christian Snyder, Meghann Cody, Jason Oakes, et al. (+4)
23 [GO] 2023―Feb―06 Stool Screening for Sars-Cov-2 RNA for COVID-19 in Patients Undergoing Hematopoietic Cell Transplantation, Cellular Therapy, and Induction Chemotherapy Christopher J. Severyn, Aravind Natarajan, Danica T. Schmidtke, Erin F Brooks, Haley Hedlin, Inna Kaplan, et al. (+2)
24 [GO] 2023―Feb―06 Long-Term Follow-up Outcomes of Patients That Underwent Allogeneic or Autologous Hematopoietic Transplant Shortly after a COVID-19 Infection Alejandro Marinos, Jeremy L Ramdial, Rima M. Saliba, Fareed Khawaja, Amin M. Alousi, Gabriela Rondon, et al. (+8)
25 [GO] 2023―Feb―06 ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies Aishwarya Sannareddy, Heather Reves, Madhusudhanan Narasimhan, Kefyalew Jaleta, Julia Marie Anderson, Hetalkumari Patel, et al. (+11)
26 [GO] 2023―Feb―06 Implementing Web-Based Pre-Transplant Essential Data (TED) Collection Module for Centralized Access: Performance Improvement Project during COVID-19 Pandemic Antonette Tariga Amao, Mahasen Saleh, Mouhab Ayas, Rafat Jafri, Seham Alqahtani, Ahmed AlAseri, et al. (+13)
27 [GO] 2023―Feb―06 Impact of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Peripheral Blood Progenitor Cell Collections in Canada Matthew Seftel, Gaganvir Parmar, Kathy Ganz, Gail Morris, Nicholas Dibdin, Karen Mostert, et al. (+5)
28 [GO] 2023―Feb―06 Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients Muhammad Umair Mushtaq, Joe S Al-Ramahi, Kevin Li, Moazzam Shahzad, Sibgha Gull Chaudhary, Andrea Nguyen, et al. (+10)
29 [GO] 2023―Feb―06 Evusheld™ Pre-Exposure COVID-19 Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant (HSCT) and Cellular Therapy Recipients: A Single Institution Retrospective Series Brittany Paige DePriest, Julie Heh, Lori Burton Donahoo, Dr. Jennifer Joi Jaroscak, Michelle Hudspeth
30 [GO] 2023―Feb―06 Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, et al. (+10)
31 [GO] 2023―Feb―06 Immunogenicity and Safety of a Heterologous COVID-19 Vaccine Regimen in Hematopoietic Stem Cell Transplant Recipients Giancarlo Fatobene, Carolina Ferreira Santos, Leonardo Jun Otuyama, Tamiris Hinsching Fernandes, Anna Helena Simões Bortulucci Lima, Bruna Del Guerra Carvalho Moraes, et al. (+8)
32 [GO] 2023―Feb―06 Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System Yaya Chu, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Janet Ayello, Lauren Harrison, et al. (+15)
33 [GO] 2023―Feb―06 Efficacy of Tixagevimab-Cilgavimab in Preventing Sars-Cov-2 in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients Mary McGann, James Davis, Kiera Roubal, Katelynn Granger, Deidra Smith, Kelly Gaffney, et al. (+5)
34 [GO] 2023―Feb―06 Efficacy of a Third Sars-Cov-2 Vaccine Dose in Allogeneic Hemopoietic Cell Recipients: a Systematic Review and Meta-Analysis Micah Rubin, Elizabeth Suelzer, Aniko Szabo, Muhammad Bilal Abid
35 [GO] 2023―Feb―06 A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210) Antonio Perez-Martinez, Cristina Ferreras, Clara Hernandez, Alejandro Martin-Quiros, Karima Al-Akioui-Sanz, Marta Mora-Rillo, et al. (+17)
36 [GO] 2023―Feb―02 Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity Post Hematopoietic Cell Transplantation Amy C. Sherman, Chi-An Cheng, Zoe Swank, Guohai Zhou, Xiaofang Li, Nicolas C. Issa, et al. (+3)
37 [GO] 2022―Nov―17 Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Lan-Ping Xu, Dao-Pei Lu, De-Pei Wu, Er-Lie Jiang, Dai-Hong Liu, He Huang, et al. (+17)
38 [GO] 2022―Oct―21 Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology Fareed Khawaja, Genovefa Papanicolaou, Sanjeet Dadwal, Steven A. Pergam, John R. Wingard, Zeinab El Boghdadly, et al. (+9)
39 [GO] 2022―Sep―11 Revised Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022) Veronica Dioverti, Zeinab El Boghdadly, Zainab Shahid, Alpana Waghmare, Maheen Abidi, Steven Pergam, et al. (+6)
40 [GO] 2022―Sep―02 Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression Shivaprasad Manjappa, Huy Q. Phi, Lik Wee Lee, Lynn Onstad, Darcy B. Gill, Laura Connelly-Smith, et al. (+5)
41 [GO] 2022―Jul―30 Safety and Immunogenicity after A Three-dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Muneyoshi Kimura, Victor H. Ferreira, Sagar Kothari, Ivan Pasic, Jonas I. Mattsson, Vathany Kulasingam, et al. (+7)
42 [GO] 2022―Jul―26 Secondary impact of the COVID-19 pandemic on patients and the cell therapy healthcare ecosystem Jane Koo, Jeffrey J. Auletta, David M. Hartley, John Huber, Samantha Jaglowski, Malika Kapadia, et al. (+10)
43 [GO] 2022―Jul―06 Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program Yoshinobu Kanda, Noriko Doki, Minoru Kojima, Shinichi Kako, Masami Inoue, Naoyuki Uchida, et al. (+14)
44 [GO] 2022―Jul―04 Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Haematopoietic Stem Cell Transplant Recipients: A Cohort Study Neel S. Bhatt, Akshay Sharma, Andrew St Martin, Muhammad Bilal Abid, Valerie I. Brown, Miguel A. Diaz, et al. (+17)
45 [GO] 2022―Jun―18 Predictors of Covid-19 Vaccination Response after in-vivo T-cell depleted Stem Cell Transplantation Ok-kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, Rosemary Soave, Tsiporah Shore, Sebastian Mayer, et al. (+7)
46 [GO] 2022―May―20 Correspondence to Immune responses to SARS-CoV-2 vaccination in young patients with anti-CD19 CAR-T-induced B-cell aplasia Andrea Jarisch
47 [GO] 2022―May―19 COVID-19 vaccination and anti-CD19 CAR-T-induced B-cell aplasia: Correspondence Pathum Sookaromdee, Viroj Wiwanitkit
48 [GO] 2022―Apr―26 Immune responses to SARS-CoV-2 vaccination in young patients with anti-CD19 CAR-T-induced B-cell aplasia Andrea Jarisch, Eliza Wiercinska, Sabine Huenecke, Melanie Bremm, Claudia Cappel, Julian Hauler, et al. (+7)
49 [GO] 2022―Mar―18 Cellular and Humoral Responses from Sars-Cov-2 Specific CD45RA- Memory T Cells from Convalescent and Naive Donors. Clinical Application As an Adoptive Cell Therapy for COVID-19 Karima AL-Akioui Sanz, Cristina Ferreras, Jose Luis Vicario, Antonio Balas, Miguel Ángel Moreno, Cristina Blasco, et al. (+2)
50 [GO] 2022―Mar―18 Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells Olle Ringden, Elham Roshandel, Ali Pirsalehi, Sepide Kazemi, Ghazaleh Sankanian, Mohammad Majidi, et al. (+7)
51 [GO] 2022―Mar―18 Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection Muhammad Salman Faisal, Ayman Saad, Alice Mims, Sumithira Vasu, Sarah A. Wall, Karilyn Larkin, et al. (+5)
52 [GO] 2022―Mar―18 Donor Selection in a Geographically Isolated Country during the COVID-19 Pandemic Laura RM Chapman, Cecilia Oswald, Lucy E Cain, Milica Araya, Nelly Coulits, Lucy C Maurice, et al. (+7)
53 [GO] 2022―Mar―18 Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic Taylor Harrison, Morgan Fillet, Anne Renteria, James Williams
54 [GO] 2022―Mar―18 Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Impact Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic Steven M. Devine, Michelle Kuxhausen, Stephen Spellman, Caitrin Bupp, Kwang Woo Ahn, Heather E. Stefanski, et al. (+3)
55 [GO] 2022―Mar―18 Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic? Ekin Kırcalı, Gül Yavuz Ermiş, Cemaleddin Öztürk, Hülya Yilmaz, Guldane Cengiz Seval, Yasin Yıldırım, et al. (+7)
56 [GO] 2022―Mar―18 Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy Natalie Wuliji, Sagun D Goyal, Mark Fesler, Abhishek R Chilkulwar, Aleksandar Babic
57 [GO] 2022―Mar―18 Did COVID-19 Push CAR-T to the Outpatient Setting? Alyssa Harris, Carina Dolan, Samuel Hohmann, Ernie Shippey, Gladys Epting
58 [GO] 2022―Mar―18 Humoral Response to COVID-19 Vaccination Given Pre-Cellular Therapy Wanes in Patients after Cellular Therapy: An Argument for Full Reimmunization Gunjan L. Shah, David J. Chung, Roni Tamari, Ioannis Politikos, Ann A. Jakubowski, Leeann Marcello, et al. (+8)
59 [GO] 2022―Mar―18 Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Julia Erin Wiedmeier-Nutor, Madiha Iqbal, Javier Muñoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, et al. (+24)
60 [GO] 2022―Mar―18 Mesenchymal Stromal Cells As a Therapeutic Intervention for COVID-19: Second Iteration of a Living Systematic Review and Meta-Analysis Aidan Kirkham, Madeline Monaghan, Adrian Bailey, Risa Shorr, Manoj Lalu, Dean Fergusson, David Allan
61 [GO] 2022―Mar―18 Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) Dimana Dimitrova, Jennifer Sponaugle, Jenna R.E. Bergerson, Jeffrey I. Cohen, Alexandra F. Freeman, Luigi D. Notarangelo, et al. (+9)
62 [GO] 2022―Mar―18 Comparison of Humoral and T-Cell Response after Sars-Cov-2 Vaccination Among Patients before and after Chimeric Antigen Receptor-Modified T Cell (CAR-T cell) Therapy Michael A Gonzalez, Jim Boonyaratanakornkit, Atif Bhatti, Jacob Keane-Candib, Meei-Li Huang, Victoria Campbell, et al. (+7)
63 [GO] 2022―Mar―18 Poor Humoral Response to Sars-Cov-2 Vaccination Early after Hematopoietic Cell Transplantation: Interim Results of Prospective Study (NCT04723706) Izabela Mazur, Mohamed Elgamal, Nancy Mikulandric, Klodiana Neme, Angela Michael German, Josephine Emole, et al. (+4)
64 [GO] 2022―Mar―18 Putative Protective Role of Sars-Cov-2-Specific T Cells in an HCT Patient Transplanted during Active COVID19 Infection Hoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, Yoonsuh Park, et al. (+14)
65 [GO] 2022―Mar―18 Response to Vaccination with Sars-CoV2 Vaccines in Patients Post Allogeneic Hematopoietic Cell Transplantation Caroline Pabst, Nora Liebers, Maria-Luisa Schubert, Laura Simons, Andrea Bondong, Mandy Wegner, et al. (+9)
66 [GO] 2022―Mar―18 An Agile Approach to ABMT Data & Workflow Innovation during a Pandemic Rebecca McDaniel, Mitchell E. Horwitz, Rhonda Garrett
67 [GO] 2022―Mar―18 Cryopreserved Versus Fresh Peripheral Blood Allogeneic Stem Cell Transplantation during COVID 19 Pandemic: A Single Center Experience Mengni Guo, Jieying Liu, Pamela Clark, Zohaib Ahmed, Anum Jalil, Juan Carlos Varela, et al. (+2)
68 [GO] 2022―Mar―18 Updated Outcomes during the Pandemic: Relationship between CD34 and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience Anastasia Martynova, Krithika Chennapan, Jack Rodman, Mindy Hsiao, Abdullah Ladha, Eric Tam, et al. (+3)
69 [GO] 2022―Mar―18 Favorable Outcomes of Pediatric Hematopoietic Cell Transplant Patients Receiving Regen-COV2 for Prophylaxis Against Severe COVID-19 Disease Rudi-Ann Tamara Graham, Muna Qayed, Kathryn S Leung, Ann E Haight, Suhag Parikh, Ben K. Watkins, et al. (+8)
70 [GO] 2022―Mar―18 An Exploration of COVID-19 Distress and Vaccine Hesitancy in Parents of Children Post Hematopoietic Stem Cell Transplant Parishma Guttoo, Joseph Stanek, Kimberly Taylor, Erika Strarz, Micah A Skeens, Hemalatha G. Rangarajan
71 [GO] 2022―Mar―18 Outcomes of Hospital-Associated Covid-19 in Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience Krithika Srinivasan, Fareed Khawaja, Sherry Cantu, Amin M. Alousi, Jeremy Ramdial, Richard E Champlin, et al. (+3)
72 [GO] 2022―Mar―18 Outcomes of COVID-19 Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients Treated with Hyperbaric Oxygen: A Case Series Shireen Usman, Janice Zhao, Omar Aljitawi
73 [GO] 2022―Mar―18 A Report from the National Marrow Donor Program: Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion Heather E. Stefanski, Jennifer Newman, Jennifer Novakovich, Jacklyn Barten, Jason Oakes, Meghann Cody, et al. (+4)
74 [GO] 2022―Mar―18 History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies Mia Djulbegovic, Melinda Gevorgian, Eline Luning-Prak, Alfred L. Garfall, Dan T. Vogl, Adam D. Cohen, et al. (+3)
75 [GO] 2022―Mar―18 Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic Amy Spallone, Fareed Khawaja, Ella Ariza-Heredia, Genovefa A Papanicolaou, Michael J. Boeckh, Sanjeet S. Dadwal, et al. (+5)
76 [GO] 2022―Mar―18 Vaccination Against Sars-Cov-2 Induces Robust Humoral Immune Response in Patients with Previous Hematologic Stem Cell Transplantation Elisa Roldan, Moraima Del Carmen Jimenez, Guillermo Villacampa, Candela Fernandez-Naval, Ana Perez, Laura Fox, et al. (+11)
77 [GO] 2022―Mar―18 A Portrait of Sars-Cov-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature Adrian Bailey, Aidan Kirkham, Madeline Monaghan, Risa Shorr, Arianne Buchan, Christopher Bredeson, David Allan
78 [GO] 2022―Mar―18 Immunogenicity of Sars-Cov-2 Vaccination in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients Muhammad Umair Mushtaq, Maggie Nelson, Cory R Bivona, Andrew Godwin, Priyanka Sharma, Grace Martin, et al. (+13)
79 [GO] 2022―Mar―18 Humoral and Cellular Immune Response to Sars-Cov-2 Vaccination in Patients with Chronic GVHD Shivaprasad Manjappa, Huy Q. Phi, Lik Wee Lee, Lynn Onstad, Darcy B. Gill, Sudeb C Dalai, et al. (+6)
80 [GO] 2022―Mar―18 Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study Marcie L. Riches, Joshua A. Hill, Michael Martens, Jeffery James Auletta, Aliyah Baluch, Kavita Bhavsar, et al. (+16)
81 [GO] 2022―Mar―18 Efficacy of Sars-Cov-2 Vaccine in Hematopoietic Stem Cell Transplantation and CAR-T Cell Therapy Patients; A Single Study Experience Eric Zhuang, Pragnan Kancharla, Abraham Attah, Gina Patrus, Yazan Samhouri, Anna Koget, et al. (+6)
82 [GO] 2022―Mar―18 Adapting to the New Normal: A Pandemic-Era Education Program Offered to Nurses Caring for Patients Receiving Cellular Therapy Jennifer Peterson, Erica Dickey
83 [GO] 2022―Mar―13 High mortality of COVID-19 early after allogeneic stem cell transplantation - a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group Judith Schaffrath, Christina Brummer, Daniel Wolff, Udo Holtick, Nicolaus Kröger, Martin Bornhäuser, et al. (+13)
84 [GO] 2022―Feb―24 B-cell aplasia is the most powerful predictive marker for poor humoral response after BNT162b2 mRNA SARS-CoV-2 vaccines in recipients of allogeneic hematopoietic stem cell transplantation Maxime Jullien, Amandine Le Bourgeois, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Marie Rimbert, et al. (+14)
85 [GO] 2022―Feb―16 Immunogenicity of a third dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with impaired B cell reconstitution after cellular therapy - a Single Center Prospective Cohort Study Ron Ram, Tal Freund, Tami Halperin, Ronen Ben-Ami, Odelia Amit, Yael Bar-On, et al. (+6)
86 [GO] 2022―Jan―31 Antibody Response to SARS-CoV-2 Vaccination in Patients Following Allogeneic Hematopoietic Cell Transplantation Alice Huang, Caroline Cicin-Sain, Chloe Pasin, Selina Epp, Annette Audigé, Nicolas J Müller, et al. (+14)
87 [GO] 2022―Jan―15 Real-world Experience of Cryopreserved Allogeneic Hematopoietic Grafts in the COVID-19 Pandemic: A Single Center Report Andriyana K. Bankova, Joseph Caveney, Bin Yao, Teresa L. Ramos, Jan Bögeholz, Kartoosh Heydari, et al. (+16)
88 [GO] 2021―Oct―12 HEMATOPOIETIC CELL TRANSPLANTATION IS FEASIBLE IN PATIENTS WITH PRIOR COVID-19 INFECTION Nishi Shah, Parastoo B. Dahi, Doris M. Ponce, Craig S. Sauter, Brian C. Shaffer, David J. Chung, et al. (+9)
89 [GO] 2021―Sep―27 STATE OF THE CAR-T: Risk of Infections with CAR-T Therapy and Determinants of SARS-CoV-2 Vaccine Responses Juliet Meir, Muhammad Abbas Abid, Muhammad Bilal Abid
90 [GO] 2021―Sep―24 Good Engraftment but Quality and Donor Concerns for Cryopreserved HPC Products Collected During the COVID-19 Pandemic. Duncan Purtill, Cheryl Hutchins, Glen Kennedy, Andrea McClean, Chris Fraser, Peter J Shaw, et al. (+17)
91 [GO] 2021―Sep―17 Return to School Practices for Pediatric Hematopoietic Cell Transplant Recipients During COVID-19 Pandemic Neel S. Bhatt, Christa Meyer, Lih-Wen Mau, Larisa Broglie, Steven Devine, Sung Won Choi, et al. (+2)
92 [GO] 2021―Sep―15 Distress in a Pandemic - The Association of the Coronavirus Disease-2019 (COVID-19) Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation (HSCT) Hermioni L. Amonoo, Carlisle EW Topping, Madison A. Clay, Matthew J. Reynolds, Julia Rice, Lauren E. Harnedy, et al. (+8)
93 [GO] 2021―Aug―24 Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination Jo-Anne H. Young
94 [GO] 2021―Jul―19 Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients Sandra Easdale, Robyn Shea, Lauren Ellis, Jessica Bazin, Kim Davis, Fiona Dallas, et al. (+6)
95 [GO] 2021―Jul―15 Safety and Tolerability of SARS-CoV-2 Emergency-Use Authorized Vaccines Allogeneic Hematopoietic Stem Cell Transplant Recipients. Haris Ali, Dat Ngo, Ahmed Aribi, Shukaib Arslan, Sanjeet Dadwal, Guido Marcucci, et al. (+4)
96 [GO] 2021―Jul―10 Impact of SARS-CoV-2 in hematopoietic stem cell transplant and CAR-T cell therapy recipients Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed, Haitham Abdelhakim, et al. (+10)
97 [GO] 2021―Jun―30 Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy - a Single Center Prospective Cohort Study Ron Ram, David Hagin, Nino Kikozashvilli, Tal Freund, Odelia Amit, Yael Bar-On, et al. (+14)
98 [GO] 2021―May―25 Attitudes about Donating Stem Cells during COVID-19 among African American and Hispanic Members of an Unrelated Donor Registry Galen E. Switzer, Megan E. Hamm, Jessica G. Bruce, Alicia Dawdani, Vidya Kuniyil, Deborah Mattila, et al. (+5)
99 [GO] 2021―May―05 Cryopreservation of unrelated hematopoietic stem cells from a blood and marrow donor bank during the COVID-19 pandemic. A nationwide survey by the Japan Marrow Donor Program Yoshinobu Kanda, Masami Inoue, Naoyuki Uchida, Yasushi Onishi, Reiko Kamata, Mika Kotaki, et al. (+10)
100 [GO] 2021―Apr―23 COVID-19 and Hematopoietic Cell Transplant Center-specific survival analysis: Can we adjust for the impact of the pandemic? Recommendations of the COVID-19 Taskforce of the 2020 CIBMTR Center Outcomes Forum John R. Wingard, Kwang Woo Ahn, Christopher Dandoy, Miguel-Angel Perales, William A. Wood, Brent Logan, et al. (+2)
101 [GO] 2021―Mar―23 The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplant Outcomes: A CIBMTR Analysis. Implications During The COVID-19 Pandemic Jack W. Hsu, Nosha Farhadfar, Hemant Murthy, Brent R. Logan, Stephanie Bo-Subait, Noelle Frey, et al. (+10)
102 [GO] 2021―Mar―07 COVID-19 Cliff Notes-A COVID-19 Multi-disciplinary Care Compendium KM Williams, PT Wilson, F Silva-Palacios, J Kebbe, AD LaBeaud, Higuita N Agudelo, et al. (+6)
103 [GO] 2021―Feb―16 Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves Mariam T Nawas, Gunjan L. Shah, Darren R. Feldman, Josel D. Ruiz, Elizabeth V. Robilotti, Anoshe A. Aslam, et al. (+22)
104 [GO] 2021―Jan―31 Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
105 [GO] 2021―Jan―31 Clinical Presentation and Outcomes of COVID-19 Following Hematopoietic Cell Transplantation Jose F. Camargo, Maria A Mendoza, Rick Y Lin, Ilona Moroz, Anthony D. Anderson, Michele I Morris, et al. (+9)
106 [GO] 2021―Jan―31 COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study Akshay Sharma, Neel S. Bhatt, Andrew St. Martin, Muhammad Bilal Abid, Jenni Bloomquist, Roy F. Chemaly, et al. (+10)
107 [GO] 2021―Jan―31 CD34+ Selection and T-Cell Add-Back Ensures Engraftment and Overall Safety with Unrelated Donor Cryopreserved Stem Cell Grafts during the COVID-19 Pandemic Randy M Windreich, Heather Stanczak, Jessie L Barnum, Paul Szabolcs
108 [GO] 2021―Jan―31 Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic Deborah Buk, Thilo Mengling, Susanne Seitz, Alexander Platz, Alexander H. Schmidt
109 [GO] 2021―Jan―31 Impact of COVID-19 Pandemic on Hematopoietic Stem Cell Transplantation (HSCT) and Immune Effector Cell (IEC) Therapies: A Large US Cancer Center Experience Katie Maurer, Anna Saucier, Haesook Kim, Utkarsh H. Acharya, Clifton Mo, Julie Porter, et al. (+7)
110 [GO] 2021―Jan―31 Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis David Allan, Meagan Green, Gail Morris, Jason T. Weiss, Nicholas Dibdin, Dena Mercer, Heidi Elmoazzen
111 [GO] 2021―Jan―31 Remdesivir Therapy for COVID-19 Pneumonia in a Pediatric Bone Marrow Transplant Patient Viney Hardit, Prasanth Narahari, Julio Barredo, Asha Pillai, Warren Alperstein, Sonia Boodram, Edward Ziga
112 [GO] 2021―Jan―31 Coronavirus-Specific T-Cells Can be Rapidly Expanded from Convalescent Donors for Potential Clinical Use Michael D. Keller, Katherine M. Harris, Susan Conway, Jessica Durkee-Shock, Mariah Jensen-Wachspress, Vaishnavi V Kankate, et al. (+25)
113 [GO] 2021―Jan―31 Immunophenotypic Profiling of Immune Cells in Patients with and without Hematologic Malignancies Affected By Sars-COV-2 Infection Gabriela Sanchez-Petitto, Forat Lutfi, Jonathan Siglin, Ali Bukhari, David Gottlieb, Aaron P. Rapoport, et al. (+2)
114 [GO] 2021―Jan―31 Sars-Cov-2 Infections in CAR T Cell Recipients Kevin O. McNerney, Caroline Diorio, Chakkapong Burudpakdee, Julie Chase, Jessica Lee, Sarah E. Henrickson, et al. (+9)
115 [GO] 2021―Jan―31 Learning at Home: Implementing an Adaptable Tele-Education Model for Autologous Transplant Caregivers amidst a Global Pandemic Samuel K. Wickham, Justin Cook Solle, Amy Emmert, Lauren Daniels, Anna Pullo, Sara Close
116 [GO] 2021―Jan―31 The Incidence of Viral Upper Respiratory Tract Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic Guneet Kaleka, Pryce Gaynor, Caspian Oliai, Wanxing Chai-Ho, Gary J. Schiller
117 [GO] 2021―Jan―31 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla Rocío Colunga-Pedraza, Julia E. Colunga-Pedraza, Andrés Gómez De León, Mónica Bustillos-Muñoz, Karen Lorena Osorno-Rodríguez, José Ángel Hawing, et al. (+9)
118 [GO] 2021―Jan―31 Adapting Virtual Care in a Global Pandemic: Telemedicine As a Useful Alternative in Clinical Practice in the Stem Cell Transplant Program at Dana-Farber Cancer Institute Justin Cook Solle, Samuel K. Wickham, Jill Tierney, Julie Porter, Vincent T. Ho, Robert Soiffer, Corey Cutler
119 [GO] 2021―Jan―31 Resiliency during a COVID 19 Pandemic: The Quality Manager Perspective Therese Dodd, James Wade Atkins, Jennifer A. Christian, Karen Collum, Heather J. Conway, Orpheulia Davis, et al. (+7)
120 [GO] 2021―Jan―14 The Intersection of Photopheresis and COVID-19 Vaccination Garrett S. Booth, Bipin N. Savani
121 [GO] 2020―Dec―31 Letter to the Editor Regarding “Pre-HCT Lung Computed Tomography as an Alternative to PFT During the COVID-19 Pandemic” Amin Pastaki Khoshbin, Rasoul Aliannejad
122 [GO] 2020―Dec―31 Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: Rapid adaptations by The National Marrow Donor Program and its network partners ensured a safe supply of donor products Jeffery J. Auletta, Jen L. Novakovich, Gretta L. Stritesky, Jeni Newman, Sade T. Fridy-Chesser, Karl Hailperin, Steven M. Devine
123 [GO] 2020―Dec―31 Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation Nina Worel, Bronwen E. Shaw, Mahmoud Aljurf, Mickey Koh, Adriana Seber, Daniel Weisdorf, et al. (+10)
 [1] 

123 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec